Show simple item record

dc.contributor.authorVicent, Lourdes
dc.contributor.authorÁlvarez-García, Jesús
dc.contributor.authorVazquez-Garcia, Rafael
dc.contributor.authorGonzález-Juanatey, José R
dc.contributor.authorRivera, Miguel
dc.contributor.authorSegovia, Javier
dc.contributor.authorPascual-Figal, Domingo A 
dc.contributor.authorBover, Ramón
dc.contributor.authorWorner, Fernando
dc.contributor.authorFernández-Avilés, Francisco
dc.contributor.authorAriza-Sole, Albert
dc.contributor.authorMartínez-Sellés, Manuel
dc.date.accessioned2023-07-17T08:25:31Z
dc.date.available2023-07-17T08:25:31Z
dc.date.issued2023-04-21
dc.identifier.citationJ Clin Med. 2023 Apr 21;12(8):3028es_ES
dc.identifier.issn2077-0383es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16254
dc.description.abstractOur aim was to determine the prognostic impact of coronary artery disease (CAD) on heart failure with reduced ejection fraction (HFrEF) mortality and readmissions. From a prospective multicenter registry that included 1831 patients hospitalized due to heart failure, 583 had a left ventricular ejection fraction of <40%. In total, 266 patients (45.6%) had coronary artery disease as main etiology and 137 (23.5%) had idiopathic dilated cardiomyopathy (DCM), and they are the focus of this study. Significant differences were found in Charlson index (CAD 4.4 ± 2.8, idiopathic DCM 2.9 ± 2.4, p < 0.001), and in the number of previous hospitalizations (1.1 ± 1, 0.8 ± 1.2, respectively, p = 0.015). One-year mortality was similar in the two groups: idiopathic DCM (hazard ratio [HR] = 1), CAD (HR 1.50; 95% CI 0.83-2.70, p = 0.182). Mortality/readmissions were also comparable: CAD (HR 0.96; 95% CI 0.64-1.41, p = 0.81). Patients with idiopathic DCM had a higher probability of receiving a heart transplant than those with CAD (HR 4.6; 95% CI 1.4-13.4, p = 0.012). The prognosis of HFrEF is similar in patients with CAD etiology and in those with idiopathic DCM. Patients with idiopathic DCM were more prone to receive heart transplant.es_ES
dc.description.sponsorshipThis research was funded by CIBERCV I and supported by the Instituto de Salud Carlos III. L.V. is funded by the Instituto de Salud Carlos III, Spain (CM20/00104 and ).es_ES
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleCoronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID37109365es_ES
dc.format.volume12es_ES
dc.format.number8es_ES
dc.identifier.doi10.3390/jcm12083028es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.3390/jcm12083028es_ES
dc.identifier.journalJournal of clinical medicinees_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Imagen Cardiovascular y Estudios Poblacionaleses_ES
dc.repisalud.institucionCNICes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CM20/00104es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/JR22/00004es_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional